Molecular Testing and Treatment Strategies in <i>RET</i>-Rearranged NSCLC Patients: Stay on Target to Look Forward

• Auteurs principaux: Maria Lucia Reale (Auteur), Valentina Bertaglia (Auteur), Angela Listì (Auteur), Silvia Novello (Auteur), Francesco Passiglia (Auteur)
• Format: Livre
• Publié: MDPI AG, 2022-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

<i>RET</i> alterations are recognized as key oncogenic drivers in different cancer types, including non-small cell lung cancer (NSCLC). Multikinase inhibitors (MKIs) with anti-<i>RET</i> activities resulted in variable efficacy with significant toxicities because of low targe...